268 related articles for article (PubMed ID: 33370300)
1. Implementation challenges and opportunities for improved mass treatment uptake for lymphatic filariasis elimination: Perceptions and experiences of community drug distributors of coastal Kenya.
Njomo DW; Kimani BW; Kibe LW; Okoyo C; Omondi WP; Sultani HM
PLoS Negl Trop Dis; 2020 Dec; 14(12):e0009012. PubMed ID: 33370300
[TBL] [Abstract][Full Text] [Related]
2. The fight against lymphatic filariasis: perceptions of community drug distributors during mass drug administration in coastal Kenya.
Kusi C; Steinmann P; Merten S
Infect Dis Poverty; 2020 Mar; 9(1):22. PubMed ID: 32114985
[TBL] [Abstract][Full Text] [Related]
3. How Thailand eliminated lymphatic filariasis as a public health problem.
Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
[TBL] [Abstract][Full Text] [Related]
4. Addressing barriers of community participation and access to mass drug administration for lymphatic filariasis elimination in Coastal Kenya using a participatory approach.
Njomo DW; Kibe LW; Kimani BW; Okoyo C; Omondi WP; Sultani HM
PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008499. PubMed ID: 32936792
[TBL] [Abstract][Full Text] [Related]
5. Increasing coverage in mass drug administration for lymphatic filariasis elimination in an urban setting: a study of Malindi Town, Kenya.
Njomo DW; Mukoko DA; Nyamongo NK; Karanja J
PLoS One; 2014; 9(1):e83413. PubMed ID: 24454703
[TBL] [Abstract][Full Text] [Related]
6. The role of personal opinions and experiences in compliance with mass drug administration for lymphatic filariasis elimination in Kenya.
Njomo DW; Amuyunzu-Nyamongo M; Magambo JK; Njenga SM
PLoS One; 2012; 7(11):e48395. PubMed ID: 23185256
[TBL] [Abstract][Full Text] [Related]
7. Using knowledge, attitudes and practice (KAP) surveys on lymphatic filariasis to prepare a health promotion campaign for mass drug administration in Alor District, Indonesia.
Krentel A; Fischer P; Manoempil P; Supali T; Servais G; Rückert P
Trop Med Int Health; 2006 Nov; 11(11):1731-40. PubMed ID: 17054754
[TBL] [Abstract][Full Text] [Related]
8. Towards elimination of Lymphatic Filariasis in Kenya: improving advocacy, communication and social mobilization activities for mass drug administration, a qualitative study.
Kibe LW; Kimani BW; Okoyo C; Omondi WP; Sultani HM; Njomo DW
Trop Dis Travel Med Vaccines; 2022 Jun; 8(1):16. PubMed ID: 35668465
[TBL] [Abstract][Full Text] [Related]
9. Elimination within reach: A cross-sectional study highlighting the factors that contribute to persistent lymphatic filariasis in eight communities in rural Ghana.
Minetti C; Tettevi EJ; Mechan F; Prada JM; Idun B; Biritwum NK; Osei-Atweneboana MY; Reimer LJ
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0006994. PubMed ID: 30608931
[TBL] [Abstract][Full Text] [Related]
10. Are census data accurate for estimating coverage of a lymphatic filariasis MDA campaign? Results of a survey in Sierra Leone.
Kamara W; Zoerhoff KL; Toubali EH; Hodges MH; Bisanzio D; Chowdhury D; Sonnie M; Magbity E; Samai M; Conteh A; Macarthy F; Baker M; Koroma JB
PLoS One; 2019; 14(12):e0224422. PubMed ID: 31856176
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of factors that shape implementation of mass drug administration for lymphatic filariasis in sub-Saharan Africa.
Silumbwe A; Zulu JM; Halwindi H; Jacobs C; Zgambo J; Dambe R; Chola M; Chongwe G; Michelo C
BMC Public Health; 2017 May; 17(1):484. PubMed ID: 28532397
[TBL] [Abstract][Full Text] [Related]
12. Perceptions of the roles, impact, challenges and needs of community drug distributors in the control and elimination of neglected tropical diseases in difficult-to-access communities in Ghana.
Forson AO; Awuah RB; Mohammed AR; Owusu-Asenso CM; Atakora SB; Akosah-Brempong G; Abdulai A; Sraku IK; Dhikrullahi SB; Attah SK; Afrane YA
BMC Infect Dis; 2023 Jul; 23(1):460. PubMed ID: 37430222
[TBL] [Abstract][Full Text] [Related]
13. Non-compliance to Mass Drug Administration Associated with the Low Perception of the Community Members About their Susceptibility to Lymphatic Filariasis in Ankobra, Ghana.
Dicko I; Coulibaly YI; Sangaré M; Sarfo B; Nortey PA
Infect Disord Drug Targets; 2020; 20(2):167-174. PubMed ID: 30727921
[TBL] [Abstract][Full Text] [Related]
14. Lymphatic filariasis elimination status: Wuchereria bancrofti infections in human populations and factors contributing to continued transmission after seven rounds of mass drug administration in Masasi District, Tanzania.
Lupenza ET; Gasarasi DB; Minzi OM
PLoS One; 2022; 17(1):e0262693. PubMed ID: 35045109
[TBL] [Abstract][Full Text] [Related]
15. How community engagement strategies shape participation in mass drug administration programmes for lymphatic filariasis: The case of Luangwa District, Zambia.
Silumbwe A; Halwindi H; Zulu JM
PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007861. PubMed ID: 31774820
[TBL] [Abstract][Full Text] [Related]
16. Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators.
Jambulingam P; Subramanian S; de Vlas SJ; Vinubala C; Stolk WA
Parasit Vectors; 2016 Sep; 9(1):501. PubMed ID: 27624157
[TBL] [Abstract][Full Text] [Related]
17. Controlling Neglected Tropical Diseases (NTDs) in Haiti: Implementation Strategies and Evidence of Their Success.
Lemoine JF; Desormeaux AM; Monestime F; Fayette CR; Desir L; Direny AN; Carciunoiu S; Miller L; Knipes A; Lammie P; Smith P; Stockton M; Trofimovich L; Bhandari K; Reithinger R; Crowley K; Ottesen E; Baker M
PLoS Negl Trop Dis; 2016 Oct; 10(10):e0004954. PubMed ID: 27706162
[TBL] [Abstract][Full Text] [Related]
18. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
[TBL] [Abstract][Full Text] [Related]
19. Community-directed treatment of lymphatic filariasis in Kenya and its role in the national programmes for elimination of lymphatic filariasis.
Wamae N; Njenga SM; Kisingu WM; Muthigani PW; Kiiru K
Afr J Health Sci; 2006; 13(1-2):69-79. PubMed ID: 17348745
[TBL] [Abstract][Full Text] [Related]
20. How elimination of lymphatic filariasis as a public health problem in the Kingdom of Cambodia was achieved.
Khieu V; Or V; Tep C; Odermatt P; Tsuyuoka R; Char MC; Brady MA; Sidwell J; Yajima A; Huy R; Ramaiah KD; Muth S
Infect Dis Poverty; 2018 Feb; 7(1):15. PubMed ID: 29463307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
